153 related articles for article (PubMed ID: 38066445)
61. Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
Black-Maier E; Kim S; Steinberg BA; Fonarow GC; Freeman JV; Kowey PR; Ansell J; Gersh BJ; Mahaffey KW; Naccarelli G; Hylek EM; Go AS; Peterson ED; Piccini JP;
Clin Cardiol; 2017 Sep; 40(9):746-751. PubMed ID: 28543401
[TBL] [Abstract][Full Text] [Related]
62. Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk.
Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
Eur Heart J Qual Care Clin Outcomes; 2022 Oct; 8(7):730-738. PubMed ID: 34694379
[TBL] [Abstract][Full Text] [Related]
63. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
[TBL] [Abstract][Full Text] [Related]
64. Prescription of oral anticoagulants and antiplatelets for stroke prophylaxis in atrial fibrillation: nationwide time series ecological analysis.
Wu J; Alsaeed ES; Barrett J; Hall M; Cowan C; Gale CP
Europace; 2020 Sep; 22(9):1311-1319. PubMed ID: 32778878
[TBL] [Abstract][Full Text] [Related]
65. Primary care provider payment models and adherence to anticoagulation in patients with atrial fibrillation.
Yang L; Guo J; Liang Q; Newman TV; Gellad WF; Hernandez I
J Manag Care Spec Pharm; 2021 Dec; 27(12):1672-1679. PubMed ID: 34818086
[No Abstract] [Full Text] [Related]
66. Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib).
Al-Khatib SM; Pokorney SD; Al-Khalidi HR; Haynes K; Garcia C; Martin D; Goldsack JC; Harkins T; Cocoros NM; Lin ND; Lipowicz H; McCall D; Nair V; Parlett L; McMahill-Walraven CN; Platt R; Granger CB
Am Heart J; 2020 Nov; 229():110-117. PubMed ID: 32949986
[TBL] [Abstract][Full Text] [Related]
67. Changes in Use of Anticoagulation in Patients With Atrial Fibrillation Within a Primary Care Network Associated With the Introduction of Direct Oral Anticoagulants.
Ashburner JM; Singer DE; Lubitz SA; Borowsky LH; Atlas SJ
Am J Cardiol; 2017 Sep; 120(5):786-791. PubMed ID: 28693744
[TBL] [Abstract][Full Text] [Related]
68. Clinical Characteristics, Oral Anticoagulation Patterns, and Outcomes of Medicaid Patients With Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF I) Registry.
O'Brien EC; Kim S; Thomas L; Fonarow GC; Kowey PR; Mahaffey KW; Gersh BJ; Piccini JP; Peterson ED
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146448
[TBL] [Abstract][Full Text] [Related]
69. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
[TBL] [Abstract][Full Text] [Related]
70. A Comparison of Oral Anticoagulant Use for Atrial Fibrillation in the Pre- and Post-DOAC Eras.
Brown JD; Shewale AR; Dherange P; Talbert JC
Drugs Aging; 2016 Jun; 33(6):427-36. PubMed ID: 27154397
[TBL] [Abstract][Full Text] [Related]
71. Left atrial thrombus despite continuous direct oral anticoagulant or warfarin therapy in patients with atrial fibrillation: insights into rates and timing of thrombus resolution.
Wu MS; Gabriels J; Khan M; Shaban N; D'Amato SA; Liu CF; Markowitz SM; Ip JE; Thomas G; Singh P; Lerman BB; Patel A; Cheung JW
J Interv Card Electrophysiol; 2018 Nov; 53(2):159-167. PubMed ID: 30078133
[TBL] [Abstract][Full Text] [Related]
72. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
73. Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis.
Reyes JL; Herzog CA; Yan H; Roetker NS; Wetmore JB
J Cardiovasc Pharmacol Ther; 2022; 27():10742484221142220. PubMed ID: 36472155
[TBL] [Abstract][Full Text] [Related]
74. Early Rhythm Control in Patients With Incident Atrial Fibrillation Who Had a Prior Stroke.
Lee SR; Choi EK; Lee SW; Han KD; Oh S; Lip GYH
JACC Clin Electrophysiol; 2023 Jul; 9(7 Pt 2):1121-1133. PubMed ID: 37495321
[TBL] [Abstract][Full Text] [Related]
75. Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.
O'Neal WT; Sandesara PB; Claxton JS; MacLehose RF; Chen LY; Bengtson LGS; Chamberlain AM; Norby FL; Lutsey PL; Alonso A
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29525778
[TBL] [Abstract][Full Text] [Related]
76. COVID-19 pandemic and trends in clinical outcomes and medication use for patients with established atrial fibrillation: A nationwide analysis of claims data.
Hernandez I; Yang L; Tang S; Cameron T; Guo J; Gabriel N; Essien UR; Magnani JW; Gellad WF
Am Heart J Plus; 2024 Jun; 42():100396. PubMed ID: 38689680
[TBL] [Abstract][Full Text] [Related]
77. Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants.
Lilja J; Själander A; Själander S
J Thromb Thrombolysis; 2024 Jan; 57(1):101-106. PubMed ID: 37704908
[TBL] [Abstract][Full Text] [Related]
78. The Impact of COVID-19 on Admissions and Management of Patients with Atrial Fibrillation Episodes in the Emergency Department.
Bilaszewski Ł; Timler W; Budrewicz K; Marczak M; Kozłowski R; Wizowska J; Timler M; Jagielski D; Dudek M; Rasmus P; Zyśko D; Timler D
Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34199795
[TBL] [Abstract][Full Text] [Related]
79. Impact of care coordination on oral anticoagulant therapy among patients with atrial fibrillation in routine clinical practice in Japan: a prospective, observational study.
Ono F; Akiyama S; Suzuki A; Ikeda Y; Takahashi A; Matsuoka H; Sasaki M; Okamura T; Yoshihara N;
BMC Cardiovasc Disord; 2019 Oct; 19(1):235. PubMed ID: 31651245
[TBL] [Abstract][Full Text] [Related]
80. Temporal Trends in Pharmacological Stroke Prevention in Patients with Acute Ischemic Stroke and Known Atrial Fibrillation.
Hellwig S; Grittner U; Herm J; Ruschmann R; Konieczny M; Endres M; Haeusler KG
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105266. PubMed ID: 32992191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
